Lmcg Investments LLC lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 13.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 144,827 shares of the company’s stock after purchasing an additional 17,283 shares during the period. Lmcg Investments LLC’s holdings in Doximity were worth $4,051,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in DOCS. Victory Capital Management Inc. increased its position in shares of Doximity by 21.3% during the fourth quarter. Victory Capital Management Inc. now owns 32,863 shares of the company’s stock worth $921,000 after purchasing an additional 5,780 shares in the last quarter. Jump Financial LLC acquired a new stake in shares of Doximity during the fourth quarter worth about $202,000. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of Doximity during the fourth quarter worth about $391,000. Norges Bank acquired a new stake in shares of Doximity during the fourth quarter worth about $35,995,000. Finally, Trexquant Investment LP increased its position in shares of Doximity by 58.9% during the fourth quarter. Trexquant Investment LP now owns 99,966 shares of the company’s stock worth $2,803,000 after purchasing an additional 37,069 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.
Doximity Trading Up 0.3 %
NASDAQ DOCS opened at $39.44 on Tuesday. The business’s 50 day moving average is $32.40 and its two-hundred day moving average is $28.75. The stock has a market capitalization of $7.31 billion, a price-to-earnings ratio of 54.78, a PEG ratio of 5.15 and a beta of 1.27. Doximity, Inc. has a 12-month low of $19.71 and a 12-month high of $39.75.
Analyst Upgrades and Downgrades
DOCS has been the topic of several recent research reports. JPMorgan Chase & Co. boosted their price target on Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research report on Monday, August 19th. Needham & Company LLC upgraded Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research report on Friday, August 9th. Bank of America boosted their price target on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research report on Friday, August 9th. Truist Financial restated a “hold” rating and issued a $35.00 price target (up previously from $31.00) on shares of Doximity in a research report on Wednesday, August 14th. Finally, Evercore ISI boosted their price target on Doximity from $29.00 to $34.00 and gave the company an “in-line” rating in a research report on Friday, August 9th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $31.27.
Check Out Our Latest Report on Doximity
Insider Transactions at Doximity
In other news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the sale, the chief financial officer now owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Kira Scherer Wampler sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $28.00, for a total value of $70,000.00. Following the completion of the sale, the director now directly owns 10,258 shares in the company, valued at approximately $287,224. The disclosure for this sale can be found here. Insiders have sold 37,951 shares of company stock valued at $1,271,018 in the last quarter. 39.40% of the stock is currently owned by corporate insiders.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Five stocks we like better than Doximity
- What Are Dividend Champions? How to Invest in the Champions
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- The How And Why of Investing in Oil Stocks
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 5 Oversold Stocks to Buy Right Now
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.